State Bank of India. Institutional Equities. 1QFY18 Result Update

Similar documents
93,707 77,814 90, NIM

Punjab National Bank

Punjab National Bank

Punjab National Bank

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

3,746 2,551 3, NIM

9,807 8,007 9, NIM

9,251 7,812 8, NIM

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Punjab National Bank

Institutional Equities

Punjab National Bank

EBITDA 5,019 4,211 5, EBITDA

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

2,09,057 1,85,859 2,17, (4.1) NIM

9,500 7,914 8, NIM

Institutional Equities

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

E&P To Stay Strong; Consumer Segment To Revive

Institutional Equities

Institutional Equities

Institutional Equities

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 1QFY18 Result Update

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

Bharat Financial Inclusion

Jamna Auto Industries

18,948 15,784 18, NIM

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Operating expenses tracked lower than core total income growth as ABL displayed continued

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Colgate-Palmolive (India)

Dalmia Bharat Enterprises

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Indian Oil Corporation

EBITDA 5,076 3, , EBITDA

Swiss Glascoat Equipments

Federal Bank. Institutional Equities. Management Meet Update

La Opala RG. Institutional Equities. 1QFY18 Result Update

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Institutional Equities

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Institutional Equities

Institutional Equities

Indian Oil Corporation

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

DCB Bank Ltd. 1 P a g e

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

DCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019

Axis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Sun Pharmaceutical Industries

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Bank of Baroda. Institutional Equities. 4QFY18 Result Update BUY

Institutional Equities

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

LIC Housing Finance Ltd

Institutional Equities

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy

Dabur India. Institutional Equities. 1QFY19 Result Update

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

The Ramco Cements. Institutional Equities. Event Update BUY

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Dalmia Bharat Enterprises

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Dalmia Bharat Enterprises

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated

State Bank of India (SBI)

Tata Consultancy Services

Transcription:

1QFY18 Result Update Institutional Equities State Bank of India 14 August 2017 Reuters: SBI.BO; Bloomberg: SBIN IN Merger With Associate Banks Accentuates The Pain State Bank of India s (SBI) annualised loan slippage ratio in 1QFY18 stood at 6.7% (Rs301bn), far above our estimate as well as street estimate. Loan slippage remained elevated as the bank was unable to monitor non-corporate (SME/agriculture/retail) loan accounts properly during the merger process, resulting in higher slippage of Rs179bn from this segment. Of the corporate segment slippage of Rs84bn, 95% of it was from the watch list. As a result, watch list eased to Rs244bn (1.4% of loan book) with 43% of the watch list pertaining to the power sector. On the back of higher write-off (Rs102bn) and recoveries (Rs67bn), gross non-performing asset or GNPA deterioration was limited by 86bps sequentially to 10%. Provision coverage ratio fell 74bps sequentially to 60.8%. The management has given guidance that non-corporate slippage will be contained within Rs300bn and recoveries at Rs168bn for FY18. Net interest income or NII declined 4% because of subdued loan disbursal and higher interest reversal on slippage. With lower focus on credit during the merger process, loan growth was miniscule at 1%. Net interest margin or NIM fell 48bps YoY to 2.4%. While there was no pick-up in corporate and SME segment credit off-take, retail segment grew relatively well at 13%. Non-interest income fell 9%, as the year-ago period includes oneoff gain from sale of stake in National Stock Exchange or NSE. Fee income grew 16%. Our current estimates are not comparable with earlier estimates as they now include associate banks numbers. We have retained our Buy rating on SBI with a target price of Rs325 (Rs355 earlier), valuing the parent at 1.4x P/ABV FY18E financials and Rs65 for subsidiaries. Valuation and outlook: Loan slippage was higher during the quarter, but the management gave guidance that it will come down significantly in subsequent quarters. SBI s assets under the watch list in the corporate segment are at a comfortable level. We also derive comfort from SBI s adequate capital cushion (Tier-I capital of 10.7%) which can rise after further disinvestment of non-core investments and the sale of stake in its life insurance subsidiary, unparalleled deposit franchise (domestic CASA deposit ratio at 42%) and incremental loans being more to A and above-rated entities. Extension of the tenure of Ms. Arundathi Bhattacharya, the current chairman, adds to the continuity, especially driving synergies from the merger of associate banks with SBI. SBI has the lowest restructured assets compared to peers. We believe SBI, being a proxy to the economy, is likely to be a major beneficiary of the economic recovery leading to lower credit costs, improvement in profitability and higher return ratios in the medium term. We are participating in AsiaMoney s Brokers Poll 2017. We would be pleased if you vote for us as the feedback helps us align our equity research offerings to meet your requirements. Click Here BUY Sector: Banking CMP: Rs280 Target Price: Rs325 Upside: 16% Hatim Broachwala, CFA Research Analyst hatim.broachwala@nirmalbang.com +91-22-3926 8068 Key Data Current Shares O/S (mn) 8,632.1 Mkt Cap (Rsbn/US$bn) 2,422.6/37.8 52 Wk H / L (Rs) 315/224 Daily Vol. (3M NSE Avg.) 15,661,150 Price Performance (%) 1 M 6 M 1 Yr SBI (1.0) 1.6 23.6 Nifty Index (0.8) 10.4 13.0 Source: Bloomberg and Y/E March (Rsmn) 1QFY18 1QFY17 4QFY17 YoY (%) QoQ (%) Interest income 5,49,054 5,44,930 5,89,690 0.8 (6.9) Interest expenses 3,72,994 3,62,480 3,79,030 2.9 (1.6) Net interest income 1,76,060 1,82,450 2,10,660 (3.5) (16.4) NIM (%) 2.4 2.8 2.7 (48bps) (38bps) Non-interest income 80,057 87,610 1,22,220 (8.6) (34.5) Operating income 2,56,117 2,70,060 3,32,880 (5.2) (23.1) Staff costs 77,245 77,820 89,140 (0.7) (13.3) Other operating expenses 60,131 54,620 70,640 10.1 (14.9) Total operating expenses 1,37,376 1,32,440 1,59,780 3.7 (14.0) Cost to income (%) 53.6 49.0 48.0 460bps 564bps Operating profit 1,18,741 1,37,620 1,73,100 (13.7) (31.4) Provisions 89,295 1,30,370 2,09,320 (31.5) (57.3) PBT 29,446 7,250 (36,220) 306.2 (181.3) Tax 9,391 3,510 (1,810) 167.5 (618.8) -Effective tax rate (%) 31.9 48.4 5.0 (1,652bps) 2,690bps Net profit 20,055 3,740 (34,410) 436.2 (158.3) EPS (Rs) 2.3 0.5 (4.3) 390.8 (153.8) BV (Rs) 265.3 265.1 265.9 0.1 (0.2) Deposits 2,60,25,342 2,29,74,260 2,58,53,200 13.3 0.7 Advances 1,80,42,189 1,79,57,850 1,95,25,070 0.5 (7.6)

Institutional Equities Exhibit 1: Financial summary Y/E March (Rsmn) FY15 FY16 FY17 FY18E FY19E Net interest income 5,50,153 5,71,948 6,18,597 7,27,311 8,53,798 Pre-provision profit 3,89,135 4,32,578 5,08,479 5,51,744 6,38,208 PAT 1,31,016 99,507 1,04,841 1,40,064 1,90,079 EPS (Rs) 17.5 12.8 13.1 16.2 22.0 ABV (Rs) 135.1 114.0 163.1 168.1 195.5 P/E (x) 12.3 16.8 16.4 13.2 9.8 P/ABV (x) 1.7 2.0 1.4 1.3 1.1 Gross NPAs (%) 4.4 6.7 7.2 8.9 8.4 Net NPAs (%) 2.1 3.8 3.7 4.6 3.8 RoA (%) 0.7 0.5 0.4 0.6 0.6 RoE (%) 10.6 7.3 6.3 6.5 7.7 1QFY18 analyst meet highlights The merger of associate banks with SBI has been complete seamlessly, but in the process SBI inherited some stressed assets from its associate banks. Rationalisation of branches (linking of accounts, allocating new account numbers, etc) and employees (training, transfer, reassignment, etc) has been completed. Loan slippage was elevated as the bank was unable to monitor retail loan accounts properly during the merger process, but the bank is positive on pulling back the slippage. ~Rs84bn slipped from corporate accounts, of which Rs4.8bn was from large corporates, specifically a large conglomerate, while Rs3.1bn slipped from mid-sized corporate accounts. 95% of corporate loan slippage was from the watch list. As regards the retail segment, slippage stood at Rs179bn which can be attributed to the following: Only accounts over Rs500mn were monitored and those below Rs500mn led to slippage. Forbearance during the demonetisation period came to an end, which contributed ~Rs20bn to slippage. Slippage from circles where farm/education loan waivers were announced also led to increased stress. However, the bank expects ~Rs30bn to flow from the respective state governments and will thus reduce this number. During the merger process, SBI officials could not follow up with the customers and hence led to nonpayment of dues. Technical glitches in importing ECH and standing instructions from associate banks also led to higher slippage. Segment-wise break-up of retail slippage is as follows: SME 35% Agriculture 40% Housing 14% Personal loan and others 11% 7% of slippage was from restructured accounts. Out of the 12 accounts identified under the Insolvency and Bankruptcy Code, SBI has an exposure of Rs500bn on which the bank already holds ~Rs199bn as provision and will provide an additional Rs86bn during the year. The bank is confident of recovering slipped loans in the coming quarters. There was a deposit-advance mismatch post merger of ~Rs260bn. The management justified this mismatch as follows: 2 State Bank of India

Feb-07 Aug-07 Jan-08 Jun-08 Nov-08 May-09 Oct-09 Mar-10 Aug-10 Jan-11 Jul-11 Dec-11 May-12 Oct-12 Apr-13 Sep-13 Feb-14 Jul-14 Dec-14 Jun-15 Nov-15 Apr-16 Sep-16 Mar-17 Aug-17 Institutional Equities The excess deposits have been deployed in treasuries for the time being. During the merger process, the bank was unwilling to lend aggressively to the corporate sector. The bank is unwilling to deploy assets in stressed asset circles. Rationalisation of branches and employees is expected to be completed by September 2017. 8,000 employees are expected to be redeployed by December 2017 and assigned new KRAs. The bank has completed payment of ex-gratia which should result in savings of ~Rs4bn per year. Interest income grew only 0.8% YoY as there was a reduction in the base rate and MCLR. Non-interest income witnessed one-time hit of Rs9,070mn. It was also lower on account of switch from AFS to HTM in treasuries. NIM should recover by 10bps-15bps as slippage is contained and interest rates come down. SBI gained 300bps market share in automobile loans. GNPAs were up 6bps YoY at 9.97% which can be attributed to the denominator effect and inheritance from associate banks. Provision coverage ratio or PCR was down at 60%, but the management is confident about raising PCR in the coming quarters. Credit costs stood at 2.48% for the quarter. The management gave guidance of 2.25% for the full year. Exhibit 2: One-year forward P/ABV (adjusting for subsidiaries) (x) 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50 - P/AdjBVPS Mean +1 SD -1 SD 3 State Bank of India

Institutional Equities Financial statements Exhibit 3: Income statement Y/E March (Rsmn) FY15 FY16 FY17 FY18E FY19E Interest Income 15,23,971 16,39,983 17,55,182 22,47,417 24,48,670 Interest expense 9,73,818 10,68,035 11,36,585 15,20,106 15,94,873 Net interest income 5,50,153 5,71,948 6,18,597 7,27,311 8,53,798 Fees 1,31,728 1,44,160 1,62,766 2,20,824 2,40,485 Other Income 94,031 1,34,294 1,91,843 1,96,703 2,08,869 Net Revenue 7,75,912 8,50,402 9,73,206 11,44,839 13,03,153 Operating Expense 3,86,777 4,17,824 4,64,728 5,93,095 6,64,945 -Employee Exp 2,35,371 2,51,138 2,64,893 3,65,997 4,02,597 -Other Exp 1,51,406 1,66,686 1,99,835 2,27,098 2,62,348 Pre-provision Profit 3,89,135 4,32,578 5,08,479 5,51,744 6,38,208 Provisions 1,95,996 2,94,836 3,59,927 3,39,526 3,50,210 -Loan Loss Provisions 1,68,636 2,98,808 3,29,056 2,90,685 3,27,935 -Investment Depreciation (5,901) 1,495 2,984 - - -Other Provisions 33,261 (5,467) 27,887 48,841 22,275 PBT 1,93,139 1,37,742 1,48,552 2,12,218 2,87,998 Taxes 62,123 38,235 43,711 72,154 97,919 PAT 1,31,016 99,507 1,04,841 1,40,064 1,90,079 Exhibit 5: Balance sheet Y/E March (Rsmn) FY15 FY16 FY17 FY18E FY19E Equity capital 7,466 7,763 7,973 8,632 8,632 Reserves & surplus 12,76,916 14,34,981 18,74,887 23,91,470 25,56,732 Shareholders funds 12,84,382 14,42,744 18,82,860 24,00,102 25,65,364 Deposits 1,57,67,933 1,73,07,225 2,04,47,514 2,85,55,687 3,16,49,411 -Current deposits 12,45,723 13,98,070 15,24,211 21,41,677 23,73,706 -Saving deposits 52,73,328 59,77,461 75,89,614 99,94,491 1,17,10,282 -Term deposit 92,48,882 99,31,693 1,13,33,689 1,64,19,520 1,75,65,423 Borrowings 20,51,503 32,33,445 31,76,937 25,69,644 28,83,125 Other liabilities 13,76,980 15,92,761 15,52,352 18,06,613 19,13,787 Total liabilities 2,04,80,798 2,35,76,174 2,70,59,662 3,53,32,046 3,90,11,687 Cash/Equivalent 17,48,613 16,74,676 17,19,716 23,71,855 26,56,477 Advances 1,30,00,264 1,46,37,004 1,57,10,780 2,06,24,825 2,30,99,804 Investments 49,50,274 57,56,517 76,59,896 1,00,95,449 1,07,91,497 Fixed Assets 93,292 1,03,893 4,29,190 5,15,028 5,66,531 Other assets 6,88,355 14,04,084 15,40,080 17,24,890 18,97,379 Total assets 2,04,80,798 2,35,76,174 2,70,59,662 3,53,32,046 3,90,11,687 Note: Numbers for FY15-FY17 are not adjusted for associate cos. Exhibit 4: Key ratios Y/E March FY15 FY16 FY17 FY18E FY19E Growth (%) NII growth 11.6 4.0 8.2 N.A. 17.4 Pre-provision profit growth 21.2 11.2 17.5 N.A. 15.7 PAT growth 20.3 (24.0) 5.4 N.A. 35.7 Business (%) Deposits growth 13.1 9.8 18.1 N.A. 10.8 Advances growth 7.5 12.6 7.3 N.A. 12.0 Business growth 10.5 11.0 13.2 N.A. 11.3 Credit deposit 82.4 84.6 76.8 72.2 73.0 CASA deposit 41.3 42.6 44.6 42.5 44.5 Operating efficiency (%) Cost-to-income 49.8 49.1 47.8 51.8 51.0 Cost-to-assets 2.0 1.9 1.8 1.9 1.8 Productivity (Rsmn) Business per branch 1,761.4 1,903.3 1,987.3 2,047.7 2,279.6 Business per employee 134.9 153.8 172.5 178.3 198.5 Profit per branch 8.0 5.9 5.8 5.8 7.9 Profit per employee 0.6 0.5 0.5 0.5 0.7 Spread (%) Yield on advances 9.0 8.4 7.9 7.4 7.4 Yield on investments 8.3 7.9 7.2 7.2 7.2 Cost of deposits 6.0 6.0 5.6 5.3 5.1 Yield on assets 8.6 8.2 7.7 8.0 7.3 Cost of funds 5.8 5.6 5.1 5.1 4.9 NIM 3.1 2.9 2.7 2.5 2.5 Capital adequacy (%) Tier I 9.6 9.9 10.4 10.7 10.2 Tier II 2.4 3.2 2.8 1.9 1.9 Total CAR 12.0 13.1 13.1 12.6 12.1 Asset quality (%) Gross NPAs 4.4 6.7 7.2 8.9 8.4 Net NPAs 2.1 3.8 3.7 4.6 3.8 Provision coverage 52.0 43.2 48.1 48.4 54.8 Provision coverage (incl. write-off) 69.4 60.7 65.9 62.4 67.5 Slippage 2.3 4.6 2.6 2.8 2.0 Credit costs 1.5 2.3 2.3 1.9 1.6 Return (%) RoE 10.6 7.3 6.3 6.5 7.7 RoA 0.7 0.5 0.4 0.4 0.5 RoRWA 1.1 0.8 0.7 0.8 0.9 Per share EPS 17.5 12.8 13.1 16.2 22.0 BV 172.0 185.8 236.2 278.1 297.2 ABV 135.1 114.0 163.1 168.1 195.5 Valuation (x) P/E 12.3 16.8 16.4 13.2 9.8 P/BV 1.3 1.2 0.9 0.8 0.7 P/ABV 1.7 2.0 1.4 1.3 1.1 4 State Bank of India

Apr-14 Jun-14 Aug-14 Oct-14 Dec-14 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 14 August 2014 Buy 2,418 2,915 8 October 2014 Buy 2,411 2,915 17 November 2014 Buy 2,785 3,200 22 December 2014 Buy 304 363 8 January 2015 Buy 301 363 16 February 2015 Buy 308 375 25 May 2015 Buy 282 375 12 August 2015 Buy 268 375 9 November 2015 Buy 244 375 12 February 2016 Buy 155 220 30 May 2016 Buy 201 240 16 August 2016 Buy 244 280 15 November 2016 Buy 272 315 13 February 2017 Buy 275 315 14 February 2017 Buy 272 335 22 May 2017 Buy 309 355 14 August 2017 Buy 280 325 Rating track graph 350 300 250 200 150 100 Not Covered Covered 5 State Bank of India

Institutional Equities Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is published by Nirmal Bang s Institutional Equities Research desk. Nirmal Bang group has other business units with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. Reports based on technical and derivative analysis may not match with reports based on a company's fundamental analysis. This report is for the personal information of the authorised recipient and is not for public distribution. This should not be reproduced or redistributed to any other person or in any form. This report is for the general information for the clients of Nirmal Bang Equities Pvt. Ltd., a division of Nirmal Bang, and should not be construed as an offer or solicitation of an offer to buy/sell any securities. We have exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but do not guarantee its accuracy or completeness. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Nirmal Bang or any persons connected with it do not accept any liability arising from the use of this document or the information contained therein. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information. Nirmal Bang or any of its connected persons including its directors or subsidiaries or associates or employees or agents shall not be in any way responsible for any loss or damage that may arise to any person/s from any inadvertent error in the information contained, views and opinions expressed in this publication. Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited. NBEPL has registered with SEBI as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. (Registration No: INH000001436-19.08.2015 to 18.08.2020). NBEPL or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. NBEPL or its associates/analyst has not received any compensation from the company covered by Analyst during the past twelve months. NBEPL /analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market-making activity of the company covered by Analyst. The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 3926 8017 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 3926 8230, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 3926 8100/8101, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 3926 8102/8103, +91 22 6636 8830 Atul Vitha Dealing Desk atul.vitha@nirmalbang.com 022-3926 8071 / 022-3926 8226 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-400013. Board No. : 91 22 3926 8000/1; Fax. : 022 3926 8010 6 State Bank of India